Cancer Letters
Volume 301, Issue 1 , Pages 17-28, 1 February 2011

Combined targeting of the VEGFr/EGFr and the mammalian target of rapamycin (mTOR) signaling pathway delays cell cycle progression and alters adhesion behavior of prostate carcinoma cells

Department of Urology, Johann Wolfgang Goethe-University, Frankfurt am Main, Germany

Received 21 June 2010; received in revised form 4 November 2010; accepted 7 November 2010. published online 01 December 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3835(10)00528-8

doi:10.1016/j.canlet.2010.11.003

Cancer Letters
Volume 301, Issue 1 , Pages 17-28, 1 February 2011

Article Tools

* Image Usage & Resolution